UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF JUNE 2020


COMMISSION FILE NUMBER 001-38976 

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F.

Form 20‑F       Form 40‑F 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1)

Yes       No     

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7)

Yes       No     

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony

 

 

 

GENMAB A/S

 

 

 

 

BY:

/s/ Anthony Pagano

 

 

Name: Anthony Pagano

 

 

Title: Executive Vice President & Chief Financial Officer

 

DATE: June 04, 2020

EXHIBIT INDEX

O

 

Exhibit

Description of Exhibit

 

 

99.1

Company Announcement Dated June 04, 2020:  Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma

 

 

Genmab A S (PK) (USOTC:GNMSF)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Genmab A S (PK) Charts.
Genmab A S (PK) (USOTC:GNMSF)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Genmab A S (PK) Charts.